Well Lead Medical Co (SHSE:603309) Cyclically Adjusted FCF per Share: ¥0.23 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603309 Well Lead Medical Co Ltd SHSE:603309
84 GF Score
Price ¥11.39
GF Value ¥14.53
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Well Lead Medical Co Cyclically Adjusted FCF per Share?

Well Lead Medical Co SHSE:603309 -0.18% 84 Cyclically Adjusted FCF per Share is ¥0.23 as of Jun. 2026. GuruFocus rates SHSE:603309 with a GF Score™ of 84/100 and a GF Value™ of ¥14.53 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Well Lead Medical Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was ¥0.257. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.23 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Well Lead Medical Co's average Cyclically Adjusted FCF Growth Rate was 43.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-26), Well Lead Medical Co's current stock price is ¥11.39. Well Lead Medical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ¥0.23. Well Lead Medical Co's Cyclically Adjusted Price-to-FCF of today is 49.52.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Well Lead Medical Co was 92.63. The lowest was 46.68. And the median was 66.26.


Well Lead Medical Co  (SHSE:603309) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Well Lead Medical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=11.39/0.23
=49.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Well Lead Medical Co was 92.63. The lowest was 46.68. And the median was 66.26.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Well Lead Medical Co Cyclically Adjusted FCF per Share Related Terms


Well Lead Medical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Well Lead Medical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Well Lead Medical Co Cyclically Adjusted FCF per Share Chart

Well Lead Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.22 0.18 0.20

Well Lead Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.18 0.20 0.21 0.23

SHSE:603309 vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Well Lead Medical Co Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Well Lead Medical Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603309
84GF Score
Well Lead Medical Co Ltd SHSE:603309
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Well Lead Medical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Well Lead Medical Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.257/116.0564*116.0564
=0.257

Current CPI (Jun. 2026) = 116.0564.

Well Lead Medical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.002 102.400 -0.002
201612 0.118 102.600 0.133
201703 -0.078 103.200 -0.088
201706 0.063 103.100 0.071
201709 -0.009 104.100 -0.010
201712 0.047 104.500 0.052
201803 -0.095 105.300 -0.105
201806 0.095 104.900 0.105
201809 -0.071 106.600 -0.077
201812 0.134 106.500 0.146
201903 -0.022 107.700 -0.024
201906 0.093 107.700 0.100
201909 0.096 109.800 0.101
201912 0.096 111.200 0.100
202003 0.017 112.300 0.018
202006 0.205 110.400 0.216
202009 0.144 111.700 0.150
202012 0.150 111.500 0.156
202103 -0.092 112.662 -0.095
202106 0.161 111.769 0.167
202109 -0.011 112.215 -0.011
202112 0.252 113.108 0.259
202203 -0.047 114.335 -0.048
202206 0.341 114.558 0.345
202209 0.223 115.339 0.224
202212 0.205 115.116 0.207
202303 0.003 115.116 0.003
202306 -0.187 114.558 -0.189
202309 -0.290 115.339 -0.292
202312 0.014 114.781 0.014
202403 -0.119 115.227 -0.120
202406 0.000 114.781 0.000
202409 -0.204 115.785 -0.204
202412 0.289 114.893 0.292
202503 -0.133 115.116 -0.134
202506 -0.036 114.907 -0.036
202509 0.218 115.471 0.219
202512 0.378 115.832 0.379
202603 -0.013 116.303 -0.013
202606 0.257 116.056 0.257

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.23 mean?
Well Lead Medical Co (SHSE:603309) has a Cyclically Adjusted FCF per Share of ¥0.23 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Well Lead Medical Co and its competitors.
Is Well Lead Medical Co's Cyclically Adjusted FCF per Share too high?
Well Lead Medical Co's current Cyclically Adjusted FCF per Share is ¥0.23. Overall, Well Lead Medical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Well Lead Medical Co's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Well Lead Medical Co's Cyclically Adjusted FCF per Share of ¥0.23 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Well Lead Medical Co and its competitors. Well Lead Medical Co's current Cyclically Adjusted FCF per Share is ¥0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Well Lead Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Well Lead Medical Co (SHSE:603309) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.53, compared to a current price of ¥11.39 — trading 21.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.23. Well Lead Medical Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Well Lead Medical Co (SHSE:603309), the current Cyclically Adjusted FCF per Share is ¥0.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Well Lead Medical Co (SHSE:603309) Overvalued in 2026?

Based on GuruFocus' analysis, Well Lead Medical Co stock appears to be undervalued. The current stock price of ¥11.39 is trading 21.6% below its estimated GF Value™ of ¥14.53. GuruFocus considers Well Lead Medical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603309:

  • Cyclically Adjusted FCF per Share: ¥0.23
  • GF Value™: ¥14.53 vs. price of ¥11.39 (21.6% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Well Lead Medical Co Business Description

Address No. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
84GF Score

Get the complete analysis for SHSE:603309

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.39
Price
¥14.53
GF Value